Rethinking the use of immunotherapy post-liver transplantation: Standardized protocols with low risk of rejection [0.03%]
移植术后免疫治疗的重新思考：低排异风险的标准方案
David P Al-Adra
David P Al-Adra
Intracardiac thrombosis during liver transplantation: A 22-year single-institution cohort study [0.03%]
22年单中心肝移植队列中的心脏内血栓形成：一项回顾性研究
Sher-Lu Pai,Jennifer Lee,Taimur Sher et al.
Sher-Lu Pai et al.
Severity of liver disease is associated with cirrhotic cardiomyopathy: A multicenter study [0.03%]
肝病严重程度与心肌病有关：一项多中心研究
Xiaohan Ying,Adesola O Oje,Anton J De Witte et al.
Xiaohan Ying et al.
Introduction: Cirrhotic cardiomyopathy (CCM) is subclinical cardiac dysfunction in patients with cirrhosis in the absence of overt coronary artery, valvular, or pericardial disease. Several complications of cirrhosis, inc...
The survival benefit of deceased donor liver transplantation using MELD 3.0: A contemporary analysis [0.03%]
应用MELD 3.0评分标准的尸体供肝移植的生存效益：一项近期研究分析
Gabrielle Jutras,John P Roberts,Amy M Shui et al.
Gabrielle Jutras et al.
The decision to proceed with liver transplant (LT) must account for the risk of death without LT and the likelihood of survival after, a concept known as "survival benefit." A 2005 study suggested that deceased donor LT (DDLT) survival bene...
Histological findings in follow-up liver biopsies up to 15 years after pediatric liver transplantation: Associations with subclinical rejection, fibrosis, and immunological markers [0.03%]
长达移植后15年的肝移植受者多次随访活检的病理改变与亚临床排异、纤维化和免疫标记的关系
Jesús Quintero-Bernabeu,Maria Teresa Salcedo-Allende,Javier Juamperez-Goñi et al.
Jesús Quintero-Bernabeu et al.
This prospective single-center cohort study evaluated histological findings in follow-up liver biopsies (fLBs) from 157 pediatric liver transplant recipients over the first 15 years post-transplant. Between June 2018 and June 2024, 204 fLBs...
Letter to the Editor: Tackling the learning curve for safe robotic living donor hepatectomy [0.03%]
致编辑的信：安全进行机器人供肝手术的学习曲线应对措施
Sorabh Kapoor,Vibha Varma,Shailesh Sable
Sorabh Kapoor
Reply: Tackling the learning curve for safe Robotic Living Donor Hepatectomy [0.03%]
回信：安全的机器人活体肝切除术的学习曲线应对策略
Shweta Mallick,Krishanunni Nair,Christi Titus Varghese et al.
Shweta Mallick et al.
Letter to the Editor: Cardiac dysfunction, N-terminal pro-B-type natriuretic peptide and acute-on-chronic liver failure: Inflaming tensions? [0.03%]
读者来信：心功能不全、脑利钠肽氨基末端前体和急性加重的慢性肝衰竭：火上浇油？
Madeleine Gill,Giovanni Guglielmi,Sarah Tan et al.
Madeleine Gill et al.
The Yin-yang of HCC management: Reconciling therapeutic hierarchy and transplant benefit in Real-World evidence [0.03%]
肝癌管理的阴阳之道：真实世界证据下的治疗分层与移植获益的平衡关系
Alessandro Vitale,Fabio Piscaglia,Angelo Sangiovanni et al.
Alessandro Vitale et al.
Baseline oral microbiome associated with post-living donor liver transplant early complications within 6 months [0.03%]
与供肝移植术后六个月内早期并发症相关的口腔基线微生物群
Rosmy Babu,Manjeet Kaur,Shvetank Sharma et al.
Rosmy Babu et al.
Background and aims: Oral dysbiosis noted in chronic liver disease (CLD). This may play a role in post-liver transplantation (LT) outcomes. This study aimed to assess the baseline oral microbiome and its association with ...